- Home
- APDN vs INM Comparison
APDN vs INM Comparison
Compare APDN & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APDN
- INM
- Stock Information
- Founded
- APDN 1983
- INM 1981
- Country
- APDN United States
- INM Canada
- Employees
- APDN N/A
- INM N/A
- Industry
- APDN Other Consumer Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- APDN Consumer Discretionary
- INM Health Care
- Exchange
- APDN Nasdaq
- INM Nasdaq
- Market Cap
- APDN 2.0M
- INM 2.3M
- IPO Year
- APDN N/A
- INM N/A
- Fundamental
- Price
- APDN $1.60
- INM $2.08
- Analyst Decision
- APDN Strong Buy
- INM
- Analyst Count
- APDN 1
- INM 0
- Target Price
- APDN $75.00
- INM N/A
- AVG Volume (30 Days)
- APDN 2.6M
- INM 15.0K
- Earning Date
- APDN 05-09-2025
- INM 05-13-2025
- Dividend Yield
- APDN N/A
- INM N/A
- EPS Growth
- APDN N/A
- INM N/A
- EPS
- APDN N/A
- INM N/A
- Revenue
- APDN $3,736,873.00
- INM $4,832,013.00
- Revenue This Year
- APDN $57.08
- INM N/A
- Revenue Next Year
- APDN $40.00
- INM N/A
- P/E Ratio
- APDN N/A
- INM N/A
- Revenue Growth
- APDN N/A
- INM N/A
- 52 Week Low
- APDN $1.45
- INM $1.99
- 52 Week High
- APDN $450.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- APDN 21.83
- INM 26.67
- Support Level
- APDN $1.45
- INM $1.99
- Resistance Level
- APDN $2.06
- INM $2.66
- Average True Range (ATR)
- APDN 0.34
- INM 0.15
- MACD
- APDN 0.09
- INM -0.05
- Stochastic Oscillator
- APDN 11.45
- INM 9.34
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.